Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005659700
Mon, 25.09.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Berlin, 25 September 2023. Eckert & Ziegler AG (ISIN DE0005659700, SDAX) today signed an agreement with POINT Biopharma Global Inc. ("POINT", NASDAQ: PNT) for the supply of carrier-free lutetium-177 (n.c.a.177Lu). The agreement has a term of ten years with a total sales volume of more than € 100 million. The lutetium-177 supply is conditional  [ … ]
Technical analysis
To the publication
Wed, 13.09.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Collaboration will develop and market Satellite Hot Labs for radiolabeling of BioGuides Berlin, Germany – 13 September 2023 – Eckert & Ziegler (ISIN DE0005659700, TecDAX) today announced they have entered into a comprehensive collaboration agreement with RefleXion Medical, Inc. (RefleXion) and Telix Pharmaceuticals Limited (ASX:TLX, Telix) to  [ … ]
Technical analysis
To the publication
Thu, 10.08.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Berlin, 10 August 2023. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) increased its sales by 10% to € 118.0 million in the first half of 2023. At € 10.9 million or € 0.52 per share, net income was € 3.5 million or 25% lower than in the same period last year. Currency effects in particular reduced the result by aro [ … ]
Technical analysis
To the publication
Fri, 21.07.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

First half of 2023: sales of 118.0 million EUR (previous year: 106.8 million EUR) profit of 10.9 million EUR (previous year: 15.4 million EUR) Forecast 2023: sales of just under 230 million EUR (confirmed) profit of around EUR 25 million (confirmed) Berlin, July 21, 2023. According to preliminary calculations, Eckert & Ziegler AG (ISIN DE00 [ … ]
Technical analysis
To the publication
Fri, 21.07.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

First half of 2023: sales of 118.0 million EUR (previous year: 106.8 million EUR) profit of 10.9 million EUR (previous year: 15.4 million EUR) Forecast 2023: sales of just under 230 million EUR (confirmed) profit of around EUR 25 million (confirmed) Berlin, July 21, 2023. According to preliminary calculations, Eckert & Ziegler AG (ISIN DE00 [ … ]
Technical analysis
To the publication
Thu, 08.06.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Würzburg, Bavaria, 8 June 2023. PentixaPharm GmbH, a developer of innovative radiopharmaceuticals fully owned by Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700; TecDax) has received the approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to start PTT101, its open-label dose escalation study to e [ … ]
Technical analysis
To the publication
Thu, 08.06.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Würzburg, Bavaria, 8 June 2023. PentixaPharm GmbH, a developer of innovative radiopharmaceuticals fully owned by Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700; TecDax) has received the approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to start PTT101, its open-label dose escalation study to e [ … ]
Technical analysis
To the publication
Wed, 07.06.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Berlin, 7 June 2023. At today's Annual General Meeting of Eckert & Ziegler AG, the shareholders approved the proposal of the Executive Board and Supervisory Board to distribute a dividend of 0.50 EUR per dividend-bearing share. All items on the agenda were accepted by the shareholders. A total of 57.75% of the share capital of Eckert & Zieg [ … ]
Technical analysis
To the publication
Wed, 07.06.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

Berlin, 7 June 2023. At today's Annual General Meeting of Eckert & Ziegler AG, the shareholders approved the proposal of the Executive Board and Supervisory Board to distribute a dividend of 0.50 EUR per dividend-bearing share. All items on the agenda were accepted by the shareholders. A total of 57.75% of the share capital of Eckert & Zieg [ … ]
Technical analysis
To the publication
Tue, 30.05.2023       Eckert & Ziegler Strahlen- und Medizintechnik AG
DE0005659700

BOSTON, Mass., May 30, 2023 – By organizing the first Boston Radionuclide Theranostics Forum and bringing together numerous renowned experts in Boston, Mass., Eckert & Ziegler underscores its leading position in the field of radiopharmaceuticals. On June 1st, 2023, the company will connect potential and existing partners as well as key industry [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 07.07.2024, Calendar Week 27, 189th day of the year, 177 days remaining until EoY.